Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

smart Mirrors supporting healthier lives of Adolescents and Young Adults after cancer

Project description

AI and smart mirrors supporting healthier lives of AYA cancer survivors

The EU-funded MAYA project empowers adolescent and young adult (AYA) cancer survivors to manage long-term cardiovascular complications resulting from cancer treatment. At its core is the iCARE health hub – a smart mirror equipped with sensors and an AI-powered conversational agent – offering personalised, continuous health monitoring and support. Using advanced AI models and real-world clinical data, MAYA aims to reduce the risk of major cardiac events by up to 40 %. The project adopts a co-research approach, engaging AYA survivors directly in the design, development and testing of solutions across European Living Labs. MAYA contributes to the EU Cancer Mission by improving quality of life and health equity for cancer survivors through innovative, inclusive and data-driven care.

Objective

MAYA addresses the third intervention outlined in the call by developing, testing, and scaling up innovative, holistic approaches and tools for managing late effects of cancer treatment in AYA cancer (of any type) survivors.

MAYA aims to empower Adolescents and Young Adults (AYA) cancer survivors to manage their cardiovascular (CV) health through digital tools that address cardiotoxic-related late effects of cancer treatment. The project envisions using the iCARE health hub, which integrates a smart mirror and an AI-powered conversational agent, to deliver personalised care and continuous monitoring. The ultimate goal is to improve cardiovascular outcomes and overall quality of life for AYA survivors by managing modifiable risk factors such as hypertension, diabetes, and obesity, with an expected reduction in the risk of major cardiac events by 30-40%.

MAYA will achieve these objectives through advanced AI-driven data analysis, real-time biomarker tracking, and participatory research methods including social innovation, multistakeholder engagement, and Living Labs. The project will test these solutions in real-world settings through clinical studies involving AYA cancer survivors in multiple European countries. By focusing on personalised interventions and continuous health monitoring, MAYA directly aligns with the objectives of the Horizon Europe work programme, particularly the Cancer Mission's goals of improving long-term health outcomes and quality of life for cancer survivors. Additionally, the project contributes to the work programme’s emphasis on innovation in healthcare and equity across diverse healthcare systems.

This action is part of the Cancer Mission cluster of projects on “Quality of life (AYA).

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-RIA - HORIZON Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MISS-2024-CANCER-01

See all projects funded under this call

Coordinator

PANEPISTIMIO IOANNINON
Net EU contribution
€ 542 625,00
Address
PANEPISTEMIOYPOLE PANEPISTEMIO IOANNINON
451 10 IOANNINA
Greece
Region
Βόρεια Ελλάδα Ήπειρος Ιωάννινα
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 542 625,00

Participants (15)